(Q34540985)

2 August 2017

title

Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor (English)

1 reference

2 August 2017

Soo-Kyung Kim

1

1 reference

2 August 2017

Zhan-Guo Gao

series ordinal

2

1 reference

2 August 2017

Lak Shin Jeong

series ordinal

3

1 reference

2 August 2017

Kenneth A Jacobson

series ordinal

4

1 reference

2 August 2017

language of work or name

1 reference

9 May 2006

1 reference

Journal of Molecular Graphics & Modelling

2 August 2017

published in

1 reference

2 August 2017

volume

25

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

562-577

1 reference

Pronounced conformational changes following agonist activation of the M(3) muscarinic acetylcholine receptor

2 August 2017

cites work

1 reference

12 December 2020

Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine Derivatives as Highly Potent and Selective Human A3Adenosine Receptor Antagonists: Influence of the Chain at the N8Pyrazole Nitrogen

1 reference

12 December 2020

A fast and efficient method to generate biologically relevant conformations

1 reference

12 December 2020

2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors.

1 reference

12 December 2020

1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies

1 reference

12 December 2020

Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position

1 reference

12 December 2020

N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors

1 reference

12 December 2020

Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation

1 reference

12 December 2020

Structure-activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists

1 reference

12 December 2020

Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.

1 reference

12 December 2020

Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moiety.

1 reference

12 December 2020

Design, synthesis and binding affinity of 3'-fluoro analogues of Cl-IB-MECA as adenosine A3 receptor ligands

1 reference

12 December 2020

Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin

1 reference

12 December 2020

Exploring distal regions of the A3 adenosine receptor binding site: sterically constrained N6-(2-phenylethyl)adenosine derivatives as potent ligands.

1 reference

12 December 2020

The elusive nature of intrinsic efficacy

1 reference

12 December 2020

Adenosine receptor agonists: from basic medicinal chemistry to clinical development

1 reference

12 December 2020

Receptor activation: what does the rhodopsin structure tell us?

1 reference

12 December 2020

Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes

1 reference

12 December 2020

Three-dimensional model for meta-II rhodopsin, an activated G-protein-coupled receptor

1 reference

12 December 2020

Use of an in situ disulfide cross-linking strategy to map proximities between amino acid residues in transmembrane domains I and VII of the M3 muscarinic acetylcholine receptor

1 reference

12 December 2020

Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states

1 reference

12 December 2020

Binding thermodynamics at the human A(3) adenosine receptor

1 reference

12 December 2020

Adenosine receptors as therapeutic targets

1 reference

12 December 2020

A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists.

1 reference

12 December 2020

Purine derivatives as ligands for A3 adenosine receptors.

1 reference

12 December 2020

Identification of Essential Residues Involved in the Allosteric Modulation of the Human A3Adenosine Receptor

1 reference

12 December 2020

Specific tryptophan UV-absorbance changes are probes of the transition of rhodopsin to its active state

1 reference

12 December 2020

A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition

1 reference

12 December 2020

Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists

1 reference

12 December 2020

Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists

1 reference

12 December 2020

(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.

1 reference

12 December 2020

Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection

1 reference

12 December 2020

Toward the active conformations of rhodopsin and the beta2-adrenergic receptor

1 reference

12 December 2020

Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor

1 reference

12 December 2020

MOPAC: a semiempirical molecular orbital program

1 reference

12 December 2020

Identification of an agonist-induced conformational change occurring adjacent to the ligand-binding pocket of the M(3) muscarinic acetylcholine receptor

1 reference

12 December 2020

Crystal structure of rhodopsin: A G protein-coupled receptor

1 reference

12 December 2020

Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells

1 reference

12 December 2020

Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moiety

1 reference

12 December 2020

Conformational changes that occur during M3 muscarinic acetylcholine receptor activation probed by the use of an in situ disulfide cross-linking strategy

1 reference

12 December 2020

Agonist-induced conformational changes in the beta2 adrenergic receptor

1 reference

12 December 2020

A fast flexible docking method using an incremental construction algorithm.

1 reference

12 December 2020

N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor

1 reference

12 December 2020

Electron crystallography reveals the structure of metarhodopsin I.

1 reference

12 December 2020

Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors

1 reference

12 December 2020

Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.

1 reference

12 December 2020

Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary

1 reference

12 December 2020

N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine and its uronamide derivatives. Novel adenosine agonists with both high affinity and high selectivity for the adenosine A2 receptor

1 reference

12 December 2020

Structure of bovine rhodopsin in a trigonal crystal form.

1 reference

12 December 2020

10.1016/J.JMGM.2006.05.004

Identifiers

DOI

1 reference

2 August 2017

0 references

1 reference